Skip to main content

Table 4 Outcomes and clinical variables between the groups.

From: Does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer?

Item

All (N = 292)

PLR ≤ 0.55 (n = 89)

PLR > 0.55 (n = 203)

P value+

NLR ≤ 3.92 (n = 226)

NLR > 3.92 (n = 66)

P value+

LOS in the hospital (days, mean ± SD)

16.0 ± 11.9

18.3 ± 12.9

15.0 ± 11.4

0.018*

15.5 ± 12.0

17.8 ± 11.7

0.027*

LOS in the ICU (days, mean ± SD)

6.3 ± 9.5

8.6 ± 10.9

5.4 ± 8.7

0.002*

5.9 ± 9.6

7.7 ± 9.1

0.062

Anastomotic leaks [n(%)]

36 (12.3)

18 (20.2)

18 (8.9)

0.006*

24 (10.6)

12 (18.2)

0.101

Complications

   

0.008*

  

0.671

 None [n(%)]

266 (91.1)

75 (84.3)

191 (94.1)

 

207 (91.6)

59 (89.4)

 

 Cardiac [n(%)]

10 (3.4)

6 (6.7)

4 (2.0)

5 (2.2)

5 (7.6)

 

 Respiratory [n(%)]

9 (3.1)

6 (6.7)

3 (1.5)

7 (3.1)

2 (3.0)

 

 Infectious [n(%)]

2 (0.7)

0

2 (1.0)

2 (0.9)

0

 

 Renal [n(%)]

5 (1.7)

2 (2.2)

3 (1.5)

5 (2.2)

0

 

Clavien-Dindo grade ≥ 3[n(%)]

40(13.7)

19 (21.3)

21 (10.3)

0.012*

25 (11.1)

15 (22.7)

0.015*

In-hospital mortality [n(%)]

9 (3.1)

5 (5.6)

4 (2.0)

0.098

2 (0.9)

7 (10.6)

< 0.001*

  1. P value+ were calculated for the comparison of groups based on the NLR and PLR values by statistical analysis; +Determined by the Mann-Whitney U test or Spearman’s rho test; *. P value < 0.05; ICU intensive care unit, LOS length of stay, NLR neutrophil-to-lymphocyte ratio, PLR platelet-to-lymphocyte ratio